Cholangiocarcinoma risk factors and the potential role of aspirin. Hepatology 2016 Sep;64(3):708-10
Date
04/27/2016Pubmed ID
27112798DOI
10.1002/hep.28613Scopus ID
2-s2.0-84987915631 (requires institutional sign-in at Scopus site) 12 CitationsAuthor List
Bagante F, Gamblin TC, Pawlik TMAuthor
Thomas Clark Gamblin MD Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AspirinBile Duct Neoplasms
Bile Ducts, Intrahepatic
Cholangiocarcinoma
Humans
Risk Factors
